Global Biologics and Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)

Publisher Name :
Date: 22-Nov-2019
No. of pages: 166

Summary

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.

The report forecast global Biologics and Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025.

The report offers detailed coverage of Biologics and Biosimilars industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Biologics and Biosimilars market for 2015-2025.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Biologics and Biosimilars according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Biologics and Biosimilars company.

Key Content of Chapters as follows (Including and can be customized) :

Part 1: Market Overview, Development, and Segment by Type, Application & Region

Part 2: Global Market by company, Type, Application & Geography

Part 3-4: Asia-Pacific Market by Type, Application & Geography

Part 5-6: Europe Market by Type, Application & Geography

Part 7-8: North America Market by Type, Application & Geography

Part 9-10: South America Market by Type, Application & Geography

Part 11-12: Middle East & Africa Market by Type, Application & Geography

Part 13: Company information, Sales, Cost, Margin etc.

Part 14: Conclusion

Market Segment as follows:

By Region

- Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania]

- Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

- North America[United States, Canada, Mexico]

- Middle East & Africa[GCC, North Africa, South Africa]

- South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

- Dong Bao

- Ganlee

- United Laboratories

Market by Type

- Antibody

- Hormone

- Growth Factors

- Others

Market by Application

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

Global Biologics and Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)

Table of Contents

Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

Part 2 Global Market Status and Future Forecast
2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

Part 3 Asia-Pacific Market Status and Future Forecast
3.1 Asia-Pacific Market by Region
3.2 Asia-Pacific Market by Type
3.3 Asia-Pacific Market by Application
3.4 Asia-Pacific Market by Forecast

Part 4 Asia-Pacific Market by Geography
4.1 China Market Status and Future Forecast
4.1.1 China Market by Type
4.1.2 China Market by Application
4.1.3 China Market by Forecast
4.2 Southeast Asia Market Status and Future Forecast
4.2.1 Southeast Asia Market by Type
4.2.2 Southeast Asia Market by Application
4.2.3 Southeast Asia Market by Forecast
4.3 India Market Status and Future Forecast
4.3.1 India Market by Type
4.3.2 India Market by Application
4.3.3 India Market by Forecast
4.4 Japan Market Status and Future Forecast
4.4.1 Japan Market by Type
4.4.2 Japan Market by Application
4.4.3 Japan Market by Forecast
4.5 Korea Market Status and Future Forecast
4.5.1 Korea Market by Type
4.5.2 Korea Market by Application
4.5.3 Korea Market by Forecast
4.6 Oceania Market Status and Future Forecast
4.6.1 Oceania Market by Type
4.6.2 Oceania Market by Application
4.6.3 Oceania Market by Forecast

Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Region
5.2 Europe Market by Type
5.3 Europe Market by Application
5.4 Europe Market by Forecast

Part 6 Europe Market by Geography
6.1 Germany Market Status and Future Forecast
6.1.1 Germany Market by Type
6.1.2 Germany Market by Application
6.1.3 Germany Market by Forecast
6.2 UK Market Status and Future Forecast
6.2.1 UK Market by Type
6.2.2 UK Market by Application
6.2.3 UK Market by Forecast
6.3 France Market Status and Future Forecast
6.3.1 France Market by Type
6.3.2 France Market by Application
6.3.3 France Market by Forecast
6.4 Italy Market Status and Future Forecast
6.4.1 Italy Market by Type
6.4.2 Italy Market by Application
6.4.3 Italy Market by Forecast
6.5 Russia Market Status and Future Forecast
6.5.1 Russia Market by Type
6.5.2 Russia Market by Application
6.5.3 Russia Market by Forecast
6.6 Spain Market Status and Future Forecast
6.6.1 Spain Market by Type
6.6.2 Spain Market by Application
6.6.3 Spain Market by Forecast
6.7 Netherlands Market Status and Future Forecast
6.7.1 Netherlands Market by Type
6.7.2 Netherlands Market by Application
6.7.3 Netherlands Market by Forecast
6.8 Turkey Market Status and Future Forecast
6.8.1 Turkey Market by Type
6.8.2 Turkey Market by Application
6.8.3 Turkey Market by Forecast
6.9 Switzerland Market Status and Future Forecast
6.9.1 Switzerland Market by Type
6.9.2 Switzerland Market by Application
6.9.3 Switzerland Market by Forecast

Part 7 North America Market Status and Future Forecast
7.1 North America Market by Region
7.2 North America Market by Type
7.3 North America Market by Application
7.4 North America Market by Forecast

Part 8 North America Market by Geography
8.1 United States Market Status and Future Forecast
8.1.1 United States Market by Type
8.1.2 United States Market by Application
8.1.3 United States Market by Forecast
8.2 Canada Market Status and Future Forecast
8.2.1 Canada Market by Type
8.2.2 Canada Market by Application
8.2.3 Canada Market by Forecast
8.3 Mexico Market Status and Future Forecast
8.3.1 Mexico Market by Type
8.3.2 Mexico Market by Application
8.3.3 Mexico Market by Forecast

Part 9 South America Market Status and Future Forecast
9.1 South America Market by Region
9.2 South America Market by Type
9.3 South America Market by Application
9.4 South America Market by Forecast

Part 10 South America Market by Geography
10.1 Brazil Market Status and Future Forecast
10.1.1 Brazil Market by Type
10.1.2 Brazil Market by Application
10.1.3 Brazil Market by Forecast
10.2 Argentina Market Status and Future Forecast
10.2.1 Argentina Market by Type
10.2.2 Argentina Market by Application
10.2.3 Argentina Market by Forecast
10.3 Columbia Market Status and Future Forecast
10.3.1 Columbia Market by Type
10.3.2 Columbia Market by Application
10.3.3 Columbia Market by Forecast
10.4 Chile Market Status and Future Forecast
10.4.1 Chile Market by Type
10.4.2 Chile Market by Application
10.4.3 Chile Market by Forecast
10.5 Peru Market Status and Future Forecast
10.5.1 Peru Market by Type
10.5.2 Peru Market by Application
10.5.3 Peru Market by Forecast

Part 11 Middle East & Africa Market Status and Future Forecast
11.1 Middle East & Africa Market by Region
11.2 Middle East & Africa Market by Type
11.3 Middle East & Africa Market by Application
11.4 Middle East & Africa Market by Forecast

Part 12 Middle East & Africa Market by Geography
12.1 GCC Market Status and Future Forecast
12.1.1 GCC Market by Type
12.1.2 GCC Market by Application
12.1.3 GCC Market by Forecast
12.2 North Africa Market Status and Future Forecast
12.2.1 North Africa Market by Type
12.2.2 North Africa Market by Application
12.2.3 North Africa Market by Forecast
12.3 South Africa Market Status and Future Forecast
12.3.1 South Africa Market by Type
12.3.2 South Africa Market by Application
12.3.3 South Africa Market by Forecast

Part 13 Key Companies
13.1 Roche
13.1.1 Company Profile
13.1.2 Products & Services Overview
13.1.3 Sales Data List
13.2 Amgen
13.3 AbbVie
13.4 Sanofi-Aventis
13.5 Johnson & Johnson
13.6 Pfizer
13.7 Novo Nordisk
13.8 Eli Lilly
13.9 Novartis
13.10 Merck
13.11 3sbio
13.12 Changchun High Tech
13.13 CP Guojian
13.14 Biotech
13.15 Gelgen
13.16 Innovent
13.17 Dong Bao
13.18 Ganlee
13.19 United Laboratories

Part 14 Conclusion

List of Tables

Table Type of Biologics and Biosimilars
Table Application of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table China Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table China Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Southeast Asia Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Southeast Asia Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table India Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table India Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Japan Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Japan Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Korea Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Korea Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Oceania Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Oceania Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Germany Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Germany Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table UK Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table UK Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table France Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table France Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Italy Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Italy Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Russia Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Russia Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Spain Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Spain Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Netherlands Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Netherlands Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Turkey Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Turkey Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Switzerland Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Switzerland Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table United States Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table United States Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Canada Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Canada Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Mexico Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Mexico Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Brazil Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Brazil Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Argentina Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Argentina Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Columbia Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Columbia Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Chile Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Chile Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Peru Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Peru Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table GCC Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table GCC Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table North Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table North Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table South Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)
Table South Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List of Figures

Figure Global Biologics and Biosimilars Market Share by Type in 2019
Figure Global Biologics and Biosimilars Market Share by Application in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019
Figure Asia Biologics and Biosimilars Market Share by Region in 2019
Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure China Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure China Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure India Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure India Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Japan Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Korea Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Oceania Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Germany Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure UK Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure UK Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure France Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure France Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Italy Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Russia Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Spain Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Turkey Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure United States Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure United States Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Canada Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Mexico Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Brazil Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Argentina Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Columbia Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Chile Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Peru Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Region in 2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure GCC Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure North Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
Figure South Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)
  • Global Biologics and Biosimilars Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 09-Jan-2020        Price: US 3480 Onwards        Pages: 139
    Summary Market Overview The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019. The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share,......
  • Japan Biosimilars- Landscape Today Outlook Tomorrow “Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinct - After a decade, JP Biosimilar guidelines’s first revision expected in FY2020 – Demonstrate Chuikyo need of biosimilar tool to curb healthcare cost- Biosimilars uptake varies as per each opportunity, Remicade BS vs. Rituxan BS – Two poles of the curve - A few skipping NHI listing due to manufacturing issues associated with constant supply need, ma
    Published: 06-Jan-2020        Price: US 4500 Onwards        Pages: 156
    Since 2009, 25 biosimilars of 12 originator products are approved in Japan and have yielded mixed performances and attained annual sales of ~¥32.4b ($300m). Unique biosimilars landscape with the entry of NESP “biosame” by originator Kyowa Hakko Kirin through its subsidiary, co-promotion/marketing collaboration with local companies for the front-end skill sets (Ayumi, Kyowa Hakko Kirin, Teijin) and few skipped listing to better manage constant supply (Pfizer), a key requirement......
  • 2020 Global Biosimilars Market Outlook
    Published: 31-Dec-2019        Price: US 2900 Onwards        Pages: 99
    The global Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China ......
  • Global Biologics and Biosimilars Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 30-Dec-2019        Price: US 2600 Onwards        Pages: 197
    In this report, we analyze the Biologics and Biosimilars industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also......
  • Global Adalimumab Biosimilar Market Data Survey Report 2015-2025
    Published: 28-Dec-2019        Price: US 1500 Onwards        Pages: 60
    Summary The global Adalimumab Biosimilar market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profil......
  • Biosimilars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Dec-2019        Price: US 3000 Onwards        Pages: 150
    Biosimilars Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilars industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilars manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Biosimilars market covering al......
  • 2017-2025 World Biologics and Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 15-Dec-2019        Price: US 2800 Onwards        Pages: 141
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • 2017-2025 World Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 15-Dec-2019        Price: US 2800 Onwards        Pages: 116
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes......
  • Global Adalimumab Biosimilar Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 12-Dec-2019        Price: US 3300 Onwards        Pages: 126
    Summary The report forecast global Adalimumab Biosimilar market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Adalimumab Biosimilar industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Adalimumab Biosimilar by geography. The report splits the market size, by volume......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs